Increase in ADHD Diagnoses and Treatment in the UK.

Increase?in ADHD Diagnoses and Treatment in the UK.

The United Kingdom has witnessed a substantial increase in ADHD diagnoses and prescriptions,?A recent study published in BJPsych Open sheds light on this concerning trend, highlighting the rise in ADHD cases across various age groups, genders, and socio-economic backgrounds. The findings point to potential healthcare inequalities and emphasise the t need for better support and resources to meet the unprecedented demand for ADHD assessments and treatments.

Researchers from University College London ?(UCL) conducted a comprehensive meta-analysis using data from IQVIA Medical Research on more than 7.6 million individuals aged 3 to 99 years. The study aimed to estimate the incidence and prevalence of ADHD diagnoses and prescriptions in both children and adults within primary care settings.

Key Findings Included:

1. Incidence and Prevalence Trends: ADHD diagnoses and prescriptions have seen a significant increase from 2000 to 2018, affecting all age groups, except for children under 5 years of age.
2. Gender Disparities: The rate of new ADHD diagnoses increased for both males and females, with higher proportions observed in boys (255 per 10,000) compared to girls (67.7 per 10,000). In adults, the diagnosis rate was higher in men (74.3 per 10,000) than in women (20 per 10,000).
3. Age-Related Patterns: Children between 6 and 9 years of age had the highest new diagnosis rates, while adults between 18 and 29 years were most affected.
4. Healthcare Inequality: Individuals residing in the most deprived areas exhibited higher rates of ADHD diagnoses and prescriptions, with rates approximately two to three times higher compared to those living in less deprived areas.
5. Relative Increase in Adults: While the absolute increase in ADHD diagnoses and prescriptions was highest in children, the relative increase was most prominent among adults, particularly men between the ages of 18 and 29.

Implications : The rise in ADHD diagnoses and treatments has sparked concerns among healthcare professionals. Lead author Dr. Doug McKechnie, from UCL's Institute of Epidemiology and Health Care, emphasized the need for better support in prescribing and monitoring ADHD medications for GPs. As awareness of ADHD continues to grow, prompt, safe, and effective care becomes essential for patients.

Dr. Peter Carpenter, chair of the Royal College of Psychiatrists’ Neurodevelopmental Special Interest Group, stressed the importance of providing NHS mental health and primary care services with sufficient resources to meet the unprecedented demand for support. Adult ADHD services, in particular, require urgent resourcing to manage growing waiting lists for assessments and provide high-quality post-diagnostic care.

Summary : The significant rise in ADHD diagnoses and treatment in the UK demands immediate attention from healthcare authorities and policymakers. Understanding the factors contributing to this trend is crucial to ensure timely and equitable access to diagnosis and treatment for all individuals affected by ADHD. By providing adequate resources and support, the healthcare system can effectively address this growing public health concern and offer better care to those in need.

References:

1. Hicks, R. (2023, July 19). Significant Rise in ADHD Diagnoses, Treatment in the UK.
2. McKechnie, D. et al. (2023). BJPsych Open. Published online July 17, 2023.

Bottom of Form